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1. Introduction  
Endophthalmitis is an infection of the anterior and posterior segments of the eye resulting 
from the introduction of microorganisms following a surgical procedure (postoperative), 
traumatic penetrating injury (posttraumatic), or metastasis from an infection of a distant site 
in the body (endogenous). Endophthalmitis can develop into panophthalmitis if the 
infectious agent invades the cornea and sclera. The vast majority of cases of endophthalmitis 
result from intraocular surgical procedures, in particular cataract surgery (West et al., 2005). 
Over the past several decades, the number of postoperative endophthalmitis cases has risen 
steadily, owing to the increase in the number of invasive ocular surgeries  performed (West 
et al., 2005).  The etiological agents responsible for endophthalmitis include both Gram-
positive and Gram-negative bacteria and fungi. Cases of post-surgical endophthalmitis are 
usually a result of the introduction of members of the normal microbiota of the eyelid and 
skin surrounding the eye, the most common cause being coagulase-negative staphylococci 
(CNS) (West et al., 2005). Cases of posttraumatic endophthalmitis are more frequently 
caused by environmental bacteria, the most common being Staphylococcus aureus and Bacillus 
cereus (Jonas et al., 2000; Meredith, 1999; O’Brien & Choic, 1995; Thompson et al., 1993). 
Frequent causes of endogenous endophthalmitis (EE) include S. aureus, streptococcal 
species, B. cereus, and Gram-negative bacteria including Klebsiella pneumoniae, Escherichia coli, 
and fungal agents such as Candida albicans (Greenwald et al., 1986; Jackson et al., 2003; 
Okada et al., 1994; Romero et al., 1999; Shammas, 1977; Shrader et al., 1990).  
The clinical hallmarks of endophthalmitis are acute vision loss, severe ocular pain, 
periorbital swelling, hypopyon, proptosis, and the presence of white cells and flare in the 
anterior chamber and vitreous (Lemley and Han, 2007). The visual prognosis can vary 
widely depending on the infectious agent, ranging from mild inflammation and full 
resolution to devastating blindness and loss of the eye. Therapy for endophthalmitis caused 
by avirulent skin microbiota typically results in complete resolution and full vision 
recovery. However, posttraumatic or endogenous endophthalmitis caused by virulent 
pathogens may not respond to therapeutic intervention and result in partial to complete 
vision loss, and in some instances, evisceration or enucleation of the infected eye.  
This chapter will present a summation of the latest findings of epidemiological studies and 
discuss current therapeutic modalities. Moreover, the bacteriology and the current state of 
knowledge regarding the pathogenesis and host/pathogen interactions will be explored. 
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Given that a number of detailed and authoritative reviews of endophthalmitis in general 
have been published in the last ten years, and given the paucity of reviews on endogenous 
bacterial endophthalmitis, this chapter will primarily focus on this route of endophthalmitis.  
2. Endogenous endophthalmitis  
2.1 Historical perspective 
Endogenous or metastatic endophthalmitis results from microorganisms seeding the 
bloodstream from a distant focus of infection and invading the posterior segment of the eye 
via a compromised blood retinal barrier (BRB) (Arevalo et al., 2010; Greenwald et al., 1986; 
Jackson et al., 2003; Okada et al., 1994; Romero et al., 1999; Shammas, 1977; Shrader et al., 
1990). While this form of endophthalmitis is rare, the potential for blindness in one or both 
eyes is high. To date, almost nothing is known about the pathogenesis of endogenous 
endophthalmitis (EE), even though this disease ranks as one of the most devastating infections 
of the eye. In the pre-antibiotic era, the majority of cases of endophthalmitis resulted in poor 
visual outcome. From 1944 to 1966, approximately 73% of endophthalmitis cases resulted in a 
final visual acuity of hand motion vision or worse. The clinical outcome of endophthalmitis 
improved somewhat upon the introduction of intravitreal antibiotics and vitrectomy (Neveu 
and Elliot, 1959; Peyman et al., 1978). Even after the introduction of intravitreal antibiotic 
therapy and vitrectomy, the visual outcome of EE has not improved significantly in over 50 
years (Jackson et al., 2003). Morever, there is a paucity of information on the pathogenic 
mechanisms of this disease from both the causative agent and host perspectives. The majority 
of patients have an underlying condition and are immunocompromised (Jackson et al., 2003). 
The leading predisposing condition of EE is diabetes mellitus type 2, but intravenous drug 
abuse, immunosuppressive agents, malignancies, and AIDS are also underlying conditions 
(Arevalo et al., 2010). Symptoms of EE typically include ocular pain, blurring or loss of vision, 
purulent discharge, and photophobia. EE may present as focal white nodules on the lens 
capsule, iris, retina, or choroid, or as a ubiquitous inflammation of multiple ocular tissues 
resulting in purulent exudate throughout the globe. In addition, inflammation can spread to 
involve the orbital soft tissue (Arevalo et al., 2010).  
EE was first identified and described by the German pathologist Rudolf Ludwig Karl Virchow 
in 1856 (Virchow, 1856). While the causative agent was not identified, it  may have been 
bacterial. In 1894, German ophthalmologist Theodor Axenfeld reported in a treatise on 
endogenous endophthalmitis that the majority of cases involved only one eye and were a 
result of the deposition of septic emboli in the uvea (Axenfeld, 1894). However, in one-third of 
cases, both eyes were affected and infection was selectively localized to the retina. Axenfeld 
postulated that although bacteria were found in all branches of the carotid and ophthalmic 
arteries, the predilection for the retina was probably due to the smaller size of the retinal 
capillaries and „the presence of areas of disease in the capillary walls favoring the lodgment 
there of micro-organisms“ (Tooker, 1938). Collins and Mayou (1925) further speculated that 
„the retina becomes infiltrated with polymorphonuclear leukocyes, which make their way 
inward, collecting in large numbers between the retina and the hyaloid membrane and in the 
neighboring vitreous“. Axenfeld noted in his writings that approximately one-third of patients 
with EE also had endocarditis, and that the vegetations were the likely source of bacteria 
infecting the eye.  In 1916, a case of unilateral EE in a 19 year-old soldier with cerebrospinal 
meningitis was described (Weakley, 1916). Gram-negative diplococci, presumably Neisseria 
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meningitidis, was cultured from both the cerebrospinal fluid and from the anterior chamber of 
the left eye. The patient was treated with repeated injections of antimeningococcus serum into 
the spinal column, which resulted in complete resolution of the meningitis. Interestingly, 
infection and inflammation of the affected eye was also resolved, leading the case author to 
speculate that the antiserum therapy may have contributed to the rapid clearance of the 
infection. Regardless of whether the antiserum had any effect on clearing the infection, the 
patient retained only perception of light visual acuity (Weakley, 1916). In 1938, Tooker 
described a case of unilateral EE in a patient that was readmitted to the hospital after having 
undergone ear surgery (Tooker, 1938). The left eye was severely inflammed and visual acuity 
was perception of light only. Blood cultures were positive for staphylococci and the patient 
expired from septicemia three days following readmission. An autopsy revealed bronchial 
pneumonia, vegetative endocarditis, and abscesses in the kidneys, spleen, and liver.  
Examination of the left eyeball revealed two primary foci in the retina and ciliary body. Tooker 
concluded that staphylococcal emboli lodged in the retinal and ciliary capillaries, entered the 
vitreous chamber, and induced a robust inflammatory response. Tooker reported that the 
patient had been in excellent condition prior to the ear surgery, blood glucose levels were 
normal, and no other underlying condition was present. It is therefore possible that a systemic 
inflammatory response induced a breakdown in the blood retinal barrier allowing 
staphylococci to invade the vitreous humor.  
Even after the introduction of antibiotic therapy, visual outcomes following EE remained 
poor. Walker and Fenwick (1962) reported a case of fulminate bilateral endophthalmitis 
following streptococcal septicemia. In spite of aggressive treatment with systemic steroids, 
hydrocortisone ointment, and local and systemic antibiotics, vision in the right eye was 
perception of light, and in the left was count fingers. More recently, Jackson et al. (2003) 
reviewed 267 cases of EE and found that the visual prognosis was uniformly poor. These 
authors offered a number of possible explanations for the poor visual outcome of EE, 
including misdiagnosis owing to the fact that EE may mimic other ocular conditions, the 
rapid progression of the disease, and the failure to recognize the overlap between ocular and 
systemic infection (Jackson et al., 2003). Since the earliest reports of EE, little progress has 
been achieved in improving the visual prognosis of this disease. This highlights the 
necessity for studies to characterize the factors that contribute to the pathogenesis of EE, 
both from the host and the bacterial perspectives. 
2.2 Epidemiology and bacteriology 
Current epidemiological studies indicate that EE accounts for approximately 2 to 15% of all 
cases of infectious endophthalmitis (Arevalo et al., 2010; Puliafito et al., 1982). The often 
poor visual outcome and potential for bilateral blindness make EE one of the most 
destructive and devastating ocular infections. In recent reviews of cases of bacterial EE, 41% 
of cases resulted in a final visual acuity of count fingers or better, 26% of infected eyes lost 
all useful vision, and 29% required enucleation or evisceration (Greenwald et al., 1986; 
Jackson et al., 2003; Shammas, 1977). The vast majority of infections are unilateral, with 
disagreement among studies as to whether there is a predilection for the right or left eye 
(Arevalo et al., 2010; Greenwald et al., 1986; Jackson et al., 2003; Okada et al., 1994). Bilateral 
infections occur in approximately 25% of patients with EE (Arevalo et al., 2010). As stated 
earlier, over 50% of EE patients have an underlying medical condition, with diabetes being 
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the most prevalent. Additional populations at risk include immunocompromised patients, 
patients with prolonged indwelling devices, and intravenous drug abusers. Sources of 
infection include suppurative liver disease, endocarditis, urinary tract infection, and 
meningitis (Jackson et al., 2003). Virtually any organism that can infect the bloodstream has 
the capability to cause EE, but frequent causes include opportunistic and environmental 
pathogens such as Staphylococcus aureus, Streptococcus sp., Clostridium septicum, coagulase-
negative Staphylococcus, Bacillus cereus, Listeria monogocytogenes, Escherichia coli, Klebsiella 
pneumoniae, Serratia marcescens, Pseudomonas aeruginosa, and Neisseria meningitidis (Arevalo et 
al., 2010). However, S. aureus and K. pneumoniae dominate as bacterial causes of Gram-
positive and Gram-negative cases of EE, respectively.  
S. aureus is a Gram-positive bacterium found as a member of the normal microbiota of skin 
and mucosa, but can cause a variety of systemic, skin, and deep tissue infections and is a 
leading cause of contact lens-associated corneal infections (Callegan et al., 1994; Callegan et 
al., 2002b). The association between S. aureus EE and the prolonged use of indwelling 
prosthetics has been reported in diabetics and patients with other underlying 
immunocompromise with increasing frequency (Jackson et al., 2003; Major et al., 2010; Ness 
and Schneider, 2009; Nixdorff et al., 2009; Okada et al., 1994). S. aureus causes the majority of 
the cases of EE in Western countries and Europe (Ho et al., 2011). The emergence of lineages 
resistant to methicillin in the 1960s has prompted a public health crisis due to the difficulty 
in treating methicillin-resistant S. aureus (MRSA) infections and the increasing trend of 
infection among individuals with fully competent immune systems. MRSA infections may 
be community acquired (CA) or healthcare-associated (HA), with CA-MRSA being easier to 
treat but considerably more virulent. Coinciding with an increase in the prevalence of 
MRSA strains is an increase in MRSA ocular infections (Blomquist, 2006; Major et al., 2010). 
Recently, Ho et al. (2011) described a series of  7 patients (8 eyes) from a single institution 
that were diagnosed with EE caused by MRSA. Treatment of these cases consisted of 
intravitreal tap and injection of vancomycin and ceftazidime, as well as intravenous 
vancomycin. While retinal detachment occurred in 6 of 8 eyes, most of the patients 
experienced improved visual acuity from initial presentation, and only one eye lost all 
vision and required enucleation. Previous reports found that only 23.5% of cases of MRSA 
EE resulted in a visual acuity better than 20/200, whereas these authors found that 37.5% of 
eyes showed a final visual acuity of better than 20/200 (Ho et al., 2011). The authors contend 
that the higher than usual retinal detachment rate observered in their study might have been 
due to the higher than normal time between onset of EE and presentation, generally a mean 
time of 3.5 to 7.1 days versus a mean time of 17 days in their study (Ho et al., 2011).  
K. pneumoniae is responsible for the majority of cases of EE due to Gram-negative bacteria 
and is the leading cause of EE throughout East Asia (Arevalo et al., 2010). Similar to MRSA, 
K. pneumoniae represents a therapeutic challenge due to increasing rates of acquisition of 
antibiotic resistance determinants. Although K. pneumoniae is found in the environment and 
as a commensal member of the gastrointestinal tract microbiota, it is also a frequent cause of 
healthcare-associated infections such as pneumonia, bacteremia, and urinary tract infections 
(Chang et al., 2002; Chuang et al., 2006; Fang et al., 2004; Fung et al., 2002;). K. pneumoniae 
has become the leading cause of pyogenic liver abscess in patients in Taiwan and other 
countries in the Far East (Chang et al., 2000; Wang et al., 1998), and reports of K. pneumoniae 
EE resulting from septicemia following pyogenic liver abscesses in diabetics are increasing 
(Chang et al., 2002; Chen et al., 2004; Chuang et al., 2006; Fang et al., 2004; Fung et al., 2002;). 
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In a case review of 18 patients with EE in Korea, Chung et al. (2011) also reported a close 
association between diabetes and infection with K. pneumoniae, and these factors were linked 
to a poor visual prognosis. These findings highlight the necessity for increased scrutiny of 
diabetic patients that present with ocular symptoms.  
2.3 Diagnosis and therapeutic modalities 
Early diagnosis and the initiation of treatment are critical to controlling infection and 
improving the visual prognosis of EE. Diagnosis of EE  is difficult to establish based on 
clinical presentation alone because of the nonspecific nature of the symptomology. 
Diagnosis is usually based on clinical presentation and additional methods such as 
fundoscopy, ultrasonography, optical coherence tomography, and magnetic resonance 
imaging (Jackson et al., 2003). When EE is suspected, cultures of blood, vitreous and 
aqueous humor, and Gram stains are criticial for confirmation (Arevalo et al., 2010).  
Symptoms of systemic disease may also be useful in diagnosis, however only 57% of 
patients with EE manifested systemic signs of infection (Okada et al., 1994). Moreover, EE 
might be missed in patients with systemic infection until ocular pain and vision loss are 
experienced. Therapy for diagnosed bacterial EE consists of administration of systemic 
antibiotics such as third generation cephalosporins, vancomycin, and aminoglycosides 
(Lemley and Han, 2007). Fourth generation fluoroquinolones are also used at the discretion 
of the physician (Lemley and Han, 2007). Therapy also consists of intravitreal injection of 1 
mg vancomyin per 0.1 ml for Gram-positive and 2.25 mg ceftazidime per 0.1 ml for Gram-
negative pathogens and/or the aminoglycoside amikacin (0.4 mg). Jackson et al. (2003) 
reported in a literature review that vitrectomy is beneficial in cases of severe EE caused by 
highly virulent organisms and increases the likelihood of a better visual outcome by 
threefold. Vitrectomy is also indicated for cases of EE complicated by retinal detachment 
(Arevalo et al., 2010). As stated earlier, however, the visual outcome of EE has not improved 
in over 50 years. The lack of clinical improvements in EE is likely due to the lack of a 
reproducible animal model in which to study this disease; a disease model would be 
beneficial in terms of therapeutic testing and analysis of pathogenesis. 
2.4 Pathogenesis 
EE is one of the most frequently blinding intraocular infections, however little is known 
about the interplay of host and bacterial factors that contribute to the development of this 
disease. Moreover, the pathogenic mechanisms underlying the migration of bacteria toward 
and into the eye, inflammation, and vision loss have not been addressed. It is also unknown 
as to why diabetes is a common predisposing condition, although there are a number of 
possible explanations. Diabetes compromises the eye both immunologically and 
architecturally, resulting in changes that may weaken the ability of the eye to exclude 
organisms during systemic infection. One of the most serious and common complications 
among diabetics, specifically those with type 2 diabetes, is diabetic retinopathy (Aiello et al., 
1998; Engler et al., 1991). During the progression of diabetic retinopathy, the vasculature, 
glia, and neurons of the retina are affected. The initial changes that occur within the retinal 
vasculature are the death of pericytes and thickening of the basement membrane, which 
lead to capillary leakage and occlusion. These changes ultimately result in macular edema, 
formation of new vessels, and neuroretinal degeneration (Asnaghi et al., 2003; Fong et al., 
2003; Martin et al., 2004; Neely and Gardner, 1998; Qaum et al., 2001; Takeda et al., 2001). 
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Increases in vascular endothelial growth factor (VEGF) and the cytokines interleukin (IL)-1┚, 
IL-6, IL-8, and tumor necrosis factor alpha (TNF┙) in diabetic retinas contribute to 
angiogenesis and to breakdown in the BRB, implying an association with inflammation in 
the disease process (Jo et al., 2010). Intercellular adhesion molecule 1 (ICAM-1) and CD18 
are upregulated and contribute to increased leukocyte adhesion to the endothelial wall. This 
is turn results in endothelial cell injury and death (Funatsu et al., 2005; Miyamoto et al., 
1998; Miyamoto et al., 1999; Schroder et al., 1991). Elevated expression of matrix 
metalloproteases in the retina may also facilitate increases in vascular permeability and 
degradation of tight junction complexes, leading to BRB dysfunction (Giebel et al., 2005). 
Retinal pigment epithelia (RPE) and vascular endothelium, barrier cells of the BRB, also 
undergo changes in hyperglycemic environments in vitro and in vivo, including increases in 
VEGF that may contribute to vascular permeability (Amrite et al., 2006; Losso et al., 2010). 
The deterioration of the BRB during the development of diabetic retinopathy may allow 
pathogens to more readily invade the interior of the eye and might partially explain the link 
between diabetes and an  increased risk of acquiring EE. Unfortunately, a clinical link 
between patients with diabetic retinopathy and EE has not been reported, only speculated. 
Retinal vascular permeability is not the only change occurring in a diabetic individual. 
Diabetes also compromises the innate immune response and depresses the ability to clear 
infections in general. Polymorphonuclear leukocytes (PMN) are of critical importance in 
clearing pathogens from the bloodstream and in the eye during acute bacterial 
endophthalmitis (Callegan et al., 1999; Ramadan et al., 2006; Ramadan et al., 2008; Wiskur et 
al., 2008). These important cells are impaired in diabetics. PMN defects in chemotaxis, 
phagocytosis, and bactericidal activity have been reported in the context of diabetes 
(Delamaire et al., 1997; Walrand et al., 2004) and PMN from diabetic mice and humans are 
incapable of phagocytizing and killing both S. aureus and K. pneumoniae (Lin et al., 2006; 
Park et al., 2009). These defects in the ability of PMNs to clear bacteria that are destined  to 
cross a compromised blood retinal barrier may also contribute to the development and 
pathogenesis of EE, but this has not been scientifically analyzed.  
Virtually nothing is known about the bacterial factors that contribute to the pathogenesis of 
EE. S. aureus and K. pneumoniae possess a repertoire of factors with demonstrable roles in the 
virulence of these species in a number of animal models of infection, however it is currently 
unknown if they contribute to the pathogenesis of EE. S. aureus expresses a number of 
adhesins, including the fibronectin binding proteins FnbpA and FnbpB (Green et al., 1995), 
the fibrinogen-binding proteins ClfA and ClfB (McDevitt et al., 1994), and the collagen 
binding protein Cna (Patti et al., 1992) that have been shown to mediate attachment to 
extracellular matrix and plasma proteins, a crucial first step in initiating infections. S. aureus 
synthesizes alpha-toxin, a cytolysin shown to be important in corneal infections (Callegan et 
al., 1994) and endophthalmitis (Booth et al., 1998; Callegan et al., 2002b). S. aureus also 
secretes a host of other secreted cytolytic toxins including the beta-, gamma- and delta-
toxins, and Panton-Valentine leukocidin (Plata et al., 2009) that may contribute to structural 
damage within the eye, or in the case of Panton-Valentine leukocidin (PVL) have either anti- 
or pro-inflammatory effects. PVL lyses neutrophils at higher concentrations but is a potent 
stimulator of the release of proinflammatory cytokines such as IL-8 at lower concentrations 
(Otto, 2010). Some strains of S. aureus are also encapsulated, rendering them resistant to 
phagocytosis and more virulent in animal models of sepsis (Luong and Lee, 2002; Thakker 
et al., 1998). Most clinical isolates of S. aureus produce either Type 5 or Type 8 capsular 
polysaccharide (Roghmann et al., 2005). The capsule of S. aureus may afford a survival 
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advantage and prevent clearance from the bloodstream as well as the vitreous humor, 
especially in diabetics with impaired clearance mechanisms.  
K. pneumoniae produces at least five major virulence factors that contribute to the 
pathogenesis of infection and include capsular serotype, hypermucoviscosity phenotype 
(HMV), lipopolysaccharide (LPS), siderophores, and pili. However, nothing is known about 
their potential contribution to EE pathogenesis. There are 77 capsular serotypes, however 
serotype K1 predominates among bacteremia, liver abscess, and EE isolates in Taiwan (Fung 
et al., 2002). Capsule production is likely to impede clearance of K. pneumoniae from the 
bloodstream and from the eye. The HMV phenotype is enriched among highly virulent, 
invasive strains of K. pneumoniae, especially those causing EE (Fang et al., 2004; Fang et al., 
2007; Fung et al., 2002; Karama et al., 2008; Keynan and Rubinstein, 2008; Lee et al., 2006). 
Strains that express this phenotype possess a thick, viscous capsule-associated 
mucopolysaccharide web (Wiskur et al., 2008). Two commonly studied genes are associated 
with HMV: magA (mucoviscosity-associated gene A), which encodes a 43 kd outer 
membrane protein that has not been characterized (Fang et al., 2004), and rmpA (regulator of 
the mucoid phenotype A), a regulatory gene that controls the synthesis of the extracapsular 
mucopolysaccharide (Nassif et al., 1989). It has been shown that HMV confers resistance to 
serum killing and phagocytosis, and contributes to virulence in mice (Fang et al., 2004). 
magA- transposon mutants, which lost the HMV phenotype displayed serum sensitivity, 
became phagocytosis susceptible, and were avirulent in a mouse model (Fang et al., 2004). 
magA was located within a 35-kb locus containing 24 open reading frames (ORFs) with 
homologies to genes involved in exopolysaccharide biosynthesis or export and glycosylation 
(Chuang et al., 2006). This locus may represent a novel pathogenicity island responsible for 
the hypervirulence seen with certain K. pneumoniae pathogenic strains (Chuang et al., 2006). 
HMV+ K. pneumoniae are the most common cause of EE in Southeast Asia, with cases of EE 
caused by HMV+ K. pneumoniae on the rise in Western countries (Keynan and Rubinstein, 
2008; Lederman and Crum, 2005). Our laboratory has previously shown that the HMV 
phenotype contributes to the pathogenesis of experimental K. pneumoniae endophthalmitis. 
In this model, an HMV+ strain caused significantly greater inflammation and greater loss of 
visual function than an HMV- strain following direct injection of bacteria into the vitreous 
(Wiskur et al., 2008). Further, the HMV+ strain was not readily cleared from the eye in this 
model (Wiskur et al., 2008). More recently, the magA gene was directly linked to the 
pathogenesis of EE in experimental K. pneumoniae endophthalmitis. Hunt et al. compared a 
wildtype HMV+ K. pneumoniae strain with an isogenic mutant defective in the magA gene, 
and found that mice infected with the magA- strain showed a significantly improved visual 
outcome relative to mice infected with the wildtype strain (Hunt et al., 2011). These results 
clearly demonstrate a role for the HMV phenotype in K. pneumoniae endophthalmitis. As 
this direct injection model circumvents systemic infection, it remains to be seen whether the 
HMV phenotype is important for crossing the BRB and establishing EBE. 
The lipopolysaccharide O side chain has been shown to confer serum resistance to K. 
pneumoniae by preventing the deposition of complement components on the bacterial cell 
membrane and the ensuing complement-mediated cell lysis (Tomas et al., 1986). It is 
therefore possible that K. pneumoniae LPS from cells migrating near the BRB might elicit 
increases in permeability in the retinal vasculature that result in leakiness, facilitating entry 
into the eye. Metrickin et al. (1995), demonstrated that E. coli LPS induced a dose-dependent 
breakdown of the BRB. The siderophores enterobactin and aerobactin could also potentially 
be involved. While enterobactin is synthesized by nearly all isolates of K. pneumoniae, 
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aerobactin is less frequently detected (Podschun et al., 1993). However, only K. pneumoniae 
isolates with capsular serotype K1 or K2 that produced aerobactin were more virulent (LD50 
<103 cfu), and transfer of the genes necessary for synthesis of aerobactin into an avirulent 
strain increased the virulence by 100-fold (Nassif and Sansonetti, 1986). K. pneumoniae 
produce two types of pili or fimbriae, type 1 and type 3, that mediate attachment to 
epithelial cells. The type 1 fimbrial adhesion gene fimH was shown to be enriched among 
blood isolates (Yu et al., 2006), and the type 3 fimbrial adhesion protein MrkD has been 
demonstrated to contribute to virulence by binding to epithelial cells of the urogenital, 
repiratory, and gastrointestinal tracts (Sebghati et al., 1998), and the type 3 fimbrial shaft 
protein MrkA is required for biofilm formation on intravenous and urinary catheters and 
human extracellular matrix (Jagnow and Clegg, 2003; Langstraat et al., 2001). It is 
conceivable that these pili mediate adherence to structures in the eye and aid in the 
establishment of EE. However, as for all of the above discussed factors, no studies have been 
conducted evaluating the importance of these virulence traits to EE pathogenesis due to the 
lack of a well-characterized animal model of this disease. 
3. Postoperative endophthalmitis  
Postoperative endophthalmitis is the most common type of endophthalmitis and most 
frequently occurs following cataract surgery, with 90% of cases occuring following this 
procedure (Lemley and Han, 2007). The rates of postoperative endophthalmitis have been 
increasing over the past several years, owing to increases in the number of cataract surgeries 
and other types of intraocular surgeries performed. This raises concerns due to the ever- 
growing population of the elderly that require cataract surgery. Millions of cataract 
surgeries are performed each year. Fortunately, the rate of occurrence of post-cataract 
endophthalmitis remains low, ranging between 0.06% and 0.25% (O’Brien et al., 2007; West 
et al., 2005). Among the types of cataract surgeries performed, phacoemulsification 
accounted for approximately 48% of the postoperative endophthalmitis cases, while 38.5% 
and 6.6% of cases followed extracapsular or intracapsular extraction, respectively (Ng et al., 
2005). Postoperative endophthalmitis can occur after other types of surgery such as 
secondary intraocular lens placement, pars plana vitrectomy, penetrating keratoplasty, and 
even after corneal suture removal (Lemley and Han, 2007).  
 
Fig. 1. Acute endophthalmitis caused by Staphylococcus aureus in a 43-year-old patient  
3 days following a triple surgical procedure (penetrating keratoplasty, cataract extraction, 
and posterior chamber intraocular lens). Note the hypopion in the anterior chamber.  
The vitreous was also involved. Reproduced with kind permission from Dr. Rumelt 
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Fig. 2. Bleb-associated endophthalmitis due to Streptococcus pneumoniae in the right eye of a 63-
year-old patient, 2 weeks after trabeculectomy.  Note the whitening of the filtering bleb due to 
inflammatory infiltrate. There was also inflammation of the anterior and posterior segment.  
The earliest sign of endophthalmitis is infiltration of the bleb by inflammatory cells, and when 
the anterior and posterior segments are still normal, this is defined as “blebitis”. Reproduced 
with kind permission from Dr. Rumelt 
Preventative measures consist of prophylactic intracameral antibiotics or prophylactic 
subconjunctival antibiotic injection following cataract surgery (Kelkar et al., 2008). Patients 
with acute postoperative endophthalmitis generally present between 1 to 2 weeks following 
surgery. Endophthalmitis has also been reported to occur after intravitreal injection of anti-
VEGF agents for the treatment of age-related macular degeneration (AMD). While the rate 
of endophthalmitis following intravitreal injection of these agents is equivalent to that of 
postoperative endophthalmitis following cataract surgery, approximately 0.16%, the 
increasing number of elderly patients requiring this type of therapy is a significant cause for 
alarm (Gragoudas et al., 2004).  
Endophthalmitis must be distinguished from sterile inflammation following surgery. 
Diagnosis is established by visual acuity measurements, fundoscopy, and ERG, followed by 
microbiological evaluation of aqueous and vitreous samples (Lemley and Han, 2007). Gram-
positive bacteria are the leading cause of postoperative endophthalmitis cases, with 
coagulase-negative staphylococcal (CNS) isolates being the most common, causing 47–70% 
of all postoperative endophthalmitis cases (Han et al., 1996). S. aureus account for 
approximately 10%, Streptococcus species for 9%, Enterococcus species for 2.2%, and Gram-
negative bacteria for approximately 6% (Han et al., 1996). Fortunately, postoperative 
endophthalmitis caused by CNS is relatively mild and is more easily resolved with 
antibiotic and anti-inflammatory therapy (Josephberg, 2006). The visual prognosis is 
generally favorable, with 84% of cases resulting in at least 20/100 visual acuity, and 50% of 
these cases resulted in 20/40 visual acuity (Josephberg, 2006). Less virulent bacteria such as 
Propionibacterium acnes and CNS, and the fungal organism Candida parapsilosis are the most 
common causative agents of chronic endophthalmitis (Lemley and Han, 2007). Patients with 
this form of endophthalmitis typically present several months following surgery (Lemley 
and Han, 2007). Postoperative endophthalmitis caused by S. aureus, species of streptococci, 
enterococci, Bacillus, and Gram-negative bacteria can cause a more explosive and fulminant 
infection. The visual outcome of severe infections is uniformly poor, with only 30% of eyes 
attaining 20/100 visual acuity (Josephberg, 2006). The primary treatment is typically a single 
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intravitreal injection of antibiotics consisting of 1.0 mg vancomycin per 0.1 ml, and 2.25 mg 
ceftazidime per 0.1 ml or 400 µg amikacin per 0.1 ml. Fourth generation fluoroquinolones 
can also be employed because of their broad spectrum of activity and usefulness against 
Gram-negative bacteria. Vitrectomy and corticosteriod therapy are are often advocated as 
adjunct treatment modalities (Lemley and Han, 2007), however corticosteriod treatment is 
still considered controversial. 
4. Posttraumatic endophthalmitis  
Posttraumatic endophthalmitis is a complication of a penetrating injury to the eye and is not 
as frequent as postoperative endophthalmitis. However, the rate of infection is higher and 
the visual prognosis is poorer following penetrating injury to the globe than following 
surgical procedures. The infection rates following traumatic injury to the globe range from 
3% to 17% (Meredith, 1999; O’Brien and Choi, 1995; Thompson et al., 1993). The rates 
increase substantially when a foreign body remains in the globe and range from 11 to 30% 
(Boldt et al., 1989; Brinton et al., 1984; Thompson et al., 1993). Other risk factors include age 
greater than 50 and a more than 24 hour delay prior to presentation (Thompson et al., 1993). 
Those patients who presented for intraocular foregin body removal greater than 24 hours 
following injury were approximately 4-fold more likely to acquire endophthalmitis 
(Thompson et al, 1993), highlighting the necessity of seeking immediate medical attention 
following penetrating injury. Staphylocci and B. cereus rank as the number one and two 
causes, respectively, and together account for 95% of cases (Das et al., 2005; Lemley and 
Han, 2007).  
 
  
Fig. 3. Fundoscopic exam of a patient with Staphylococcus aureus endophthalmitis after a 
penetrating ocular injury. The findings of endophthalmitis in the vitreous may include not 
only flare and cells, but also fibrin in various degrees of organization. Organization to 
fibrotic bands may results in traction retinal detachment due to contraction of such bands. 
Reproduced with kind permission from Dr. Rumelt 
B. cereus is ten times more likely to be the causative agent of posttraumatic than 
postoperative endophthalmitis, especially in cases involving organic or soil-contaminated 
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intraocular foreign bodies (Das et al., 2005). Other causative agents include CNS, 
streptococcal species, clostridial species, fungi, and protozoa such as acanthamoeba (Lemley 
and Han, 2007; Rumelt et al., 2001).  
 
 
Fig. 4. Gross pathologic specimen of the globe affected by Pseudomonas aeruginosa 
endophthalmitis.  The patient lost his vision in the eye and it became a blind, painful eye 
that underwent enucleation.  Note the massive necrosis of the ocular tissues. Reproduced 
with kind permission from Dr. Rumelt 
 
 
Fig. 5A. Endophthalmitis caused by the gas-forming bacterium Clostridium bifermentans.   
The endophthalmitis was caused following ocular penetrating injury be a soiled-
contaminated foreign body. Note the brownish discoloration of the conjunctiva and a 
subconjunctival gas bubble. The patient was treated with intravenous and intravitreal 
panicillin and clyndamycin, but lost his vision despite the treatment. Reproduced with kind 
permission from Elsevier, Inc., in Rehany U, Dorenboim Y, Lefler E, Schirer E. 
Ophthalmology. 1994;101:839-42. 
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Fig. 5B. The same patient as in 5A a few days later.  Note that the conjunctiva has become 
necrotic, the color became purple, and the gas bubble ruptured. Reproduced with kind 
permission from Elsevier, Inc., in Rehany U, Dorenboim Y, Lefler E, Schirer E. 
Ophthalmology. 1994;101:839-42. 
When penetrating injury occurs, the foreign body should be removed as soon as possible, 
especially when the material is organic or soil contaminated due to the potential for B. cereus 
contamination (Lemley and Han, 2007). In some cases, for example where the foreign body 
is inert glass and is located in a sensitive position such as the retina, it may not be desirable 
to remove the object. Even relatively minor injuries to the eye can result in severe 
endophthalmitis with devastating outcomes. Cases have been described following 
penetrating injury to the eye due to orthodontic headgear (Blum-Hareuveni et al., 2006). 
Diagnosis of posttraumatic endophthalmitis is established by visual acuity tests, slit-lamp 
examination, and ophthalmoscopy, as well as computed tomography and ultrasound 
(Lemley and Han, 2007). For posttraumatic endopthalmitis, treatment consists of 
administration of intravitreal 1 mg vancomycin per 0.1 ml, 2.25 mg ceftazidime per 0.1 ml or 
400 µg amikacin per 0.1 ml (Lemley and Han, 2007). Even with early therapy, the outcomes 
are often poor due to the potential virulence of the infecting bacterium and the explosive 
inflammatory response. 
5. Experimental endophthalmitis and the roles of bacterial and host factors 
A rabbit model of experimental endophthalmitis has been used to assess the contribution of 
both bacterial and host factors to the development of endophthalmitis. This model mimics 
the infection course after introduction of bacteria directly into the posterior segment of the 
eye that would occur following a surgical procedure or penetrating injury, but does not 
allow for the analysis of host immunological status and bacterial factors that contribute to 
the development of EE. This model system allows intravitreal injection across the pars plana 
of low inocula that allow the bacterium under study to adapt to the intraocular environment 
of the eye and replicate (Booth et al., 1995; Booth et al., 1997; Callegan et al., 1999a; Jett et al., 
1992; Sanders et al., 2010; Sanders et al., 2011). Depending on the infecting organisms, 
infection symptoms in the rabbit model develop over a period ranging from 6 hours to 3 
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days, and a number of infection parameters can be repeatedly monitored and quantitative 
data obtained. Parameters that can be monitored include ocular inflammation, fibrin 
deposition, electrophysiologic measurement of retinal function, and bacterial growth and 
distribution. Infiltration of inflammatory cells can be quantified by slit lamp biomicroscopy 
in which progressive inflammation is scored in different anatomical locations within the eye 
(Callegan et al., 1999a). Inflammation and fibrin deposition can be qualitatively assessed by 
analysis of thin-section histopathology. Retinal damage as a result of the production of toxin 
by the bacterium under study or by bystander damage due to PMN activity in the eye can 
be measured by electroretinography (ERG). Using the rabbit model, Callegan et al. (1999a) 
found that supernatants from from B. cereus and S. aureus caused retinal damage and were 
highly inflammogenic, suggesting that secreted toxins are of primary importance to the 
pathogenesis of endophthalmitis.  Callegan and colleagues did not find individual roles for 
the B. cereus membrane damaging toxins hemolysin BL, phosphatidylinositol-specific 
phopholipase C, and phosphatidylcholine-specific phospholipase C in this model, however, 
other toxins controlled by the global regulator plcR were found to contribute to pathogenesis 
of experimental B. cereus endophthalmitis (Callegan et al., 1999b; Callegan et al., 2002a; 
Callegan et al., 2003). The S. aureus alpha- and beta-toxins, but not the gamma-toxin, were 
shown to make an important contribution to endophthalmitis (Booth et al., 1998; Callegan et 
al., 2002b). Isogenic mutants deficient in each of the toxin-encoding genes were compared in 
this model. Injection of rabbit eyes with the gamma-toxin deficient mutant had no impact on 
retinal function when compared with the wildtype strain. However, the alpha- and beta-
toxin deficient mutants were  attenuated when compared with the wildtype. After 2 days, 
rabbit eyes infected with the alpha- or beta-toxin deficient mutant showed 40% and 60% 
retinal function retained, respectively, as compared with 20% retained in rabbits infected 
with the wildtype strain. Moreover, a cumulative effect was observed as a result of 
inactivation of all three toxin loci on retention of retinal function (Callegan et al., 2002b). 
This model has also been used as a sensitive measure of the contribution of enterococcal 
virulence factors to pathogenesis. Jett et al. (1992) demonstrated that the course and severity 
of disease was significantly determined by the E. faecalis biocomponent cytolysin. The 
cytolysin destroyed the neural tissue of the retina and its architecture over a period of 24 – 
72 hours. The toxicity to retinal tissue was not attenuated by either antibiotic and/or anti-
inflammatory therapy when infection involved a cytolytic strain, although an isogenic, non-
cytolytic infection completely resolved when both of these treatments were provided 24 h 
postinfection. These studies showed not only the contribution of the cytolysin to the 
pathogenesis of enterococcal endophthalmitis, but also the importance of inflammatory 
sequelae. Engelbert et al. (2004) demonstrated that the E. faecalis gelatinase and serine 
protease in concert contributed to pathogenesis in this model as double mutants in these 
genes were significantly attenuated when compared to the single mutants.  Callegan et al. 
(1999a) also utilized this model to implicate the contribution of bacterial cell wall 
components in inciting an inflammatory response during endophthalmitis. Injection of 
metabolically inactive bacteria or cell wall sacculi elicited significant intraocular 
inflammation. The rabbit model has also been used to implicate the Streptococcus pneumoniae 
capsule in the pathogenesis of endopthalmitis (Sanders et al., 2011). Infection with an 
isogenic unencapsulated S. pneumoniae mutant strain resulted in significantly lower slit lamp 
examination scores, significantly greater retinal function, and significantly less neutrophil 
infiltration into the eye compared with the wildtype parental strain in this model. Moreover, 
they demonstrated the efficacy of immunizing with the S. pneumoniae pneumolysin in 
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protecting the eye from retinal damage during S. pneumoniae endophthalmitis (Sanders et 
al., 2010). In summary, the rabbit model of experimental endophthalmitis has proven 
invaluable in assessing the role of bacterial virulence factors and identifiying potentially 
new therapeutic targets.  
More recently, a mouse model of experimentally induced endophthalmitis has been 
employed to explore various aspects of disease development, course, and outcome. As with 
the rabbit model, infection parameters can be qualitatively and quantitatively measured 
including bacterial growth, ocular inflammation, and retinal function. Ocular inflammation 
can be qualitatively assessed via thin-section histopathology as well as quantified by slit-
lamp biomicrosopy and indirect measurements of PMN influx by a myeloperoxidase ELISA 
(Ramadan et al., 2006). As stated earlier, Wiskur et al. (2008) implicated the HMV phenotype 
in the persistence of K. pneumoniae in the eye by comparing the bacterial growth of an 
HMV+ to that of an HMV- strain after intravitreal injection of 100 CFU. The HMV- strain 
did not grow to the same level as the HMV+ strain and were cleared with 27 hours. HMV+ 
infected eyes underwent phthisis within 24 hours. This study provided evidence that the 
HMV phenotype makes an important contribution to K. pneumoniae endophthalmitis 
pathogenesis. As discussed above, Hunt et al. (2011) confirmed these findings using a magA- 
mutant of K. pneumoniae in the mouse endophthalmitis model. S. aureus cell wall teichoic 
acids have also been shown to  contribute to the pathogenesis of endophthalmitis and that 
inhibitors of cell wall teichoic acid synthesis might serve as candidates for therapy of S. 
aureus endophthalmitis in this model (Suzuki et al., 2011).  
An important aspect of the murine model of experimental endophthalmitis is that factors of 
the host immune system can be assessed by comparison of the infection course in genetic 
knockout mouse strains with that in wildtype strains of the same genetic background. 
Ramadan and colleagues (2006) showed that as early as 4 hours post-injection with B. cereus, 
significant decline in retinal function and PMN infiltration were observed, which coincided 
with an increase in the proinflammatory cytokine TNF-┙. In TNF-┙ knockout mice, B. cereus 
replicated more rapidly, retinal function declined more sharply, and fewer PMN infiltrated 
the eye. These findings illustrate the power of this model in allowing the repeated 
measurement of multiple infection parameters and showed that damage to the retina 
occurred earlier than was previously thought. Furthermore, the necessity of TNF-┙ in PMN 
recruitment and control of B. cereus replication was established. Engelbert and Gilmore 
(2005) used C3 and FasL knockout out mice to dissect components of the innate immune 
and ocular immune privilege systems in controlling S. aureus endophthalmitis. The infection 
course in C3 knockout eyes followed a similar course to their wildtype counterparts, 
suggesting that complement does not play a significant role in ocular defense against S. 
aureus infection. On the other hand, the membrane-bound Fas ligand (FasL), which 
functions to maintain the immune privilege status of the eye by inducing apoptosis in 
infiltrating inflammatory cells, was found to be criticial in bacterial clearance. Mice deficient 
in FasL were unable to control S. aureus infection after injection of an inoculum that is 
cleared in wildtype mice (Engelbert and Gilmore, 2005). The host heat shock protein alphaB-
crystallin was shown to be upregulated in the retina and prevent apoptosis and retinal 
damage during murine S. aureus endopthalmitis (Whiston et al., 2008). These authors found 
that mice deficient in the production of this molecular chaperone displayed increased retinal 
apoptosis and damage, and that S. aureus produced a protease capable of cleaving this 
www.intechopen.com
 
Endophthalmitis 
 
333 
protective protein. Finally, Kumar et al. (2010) suggested that the host toll-like receptor 
(TLR) 2 is involved in controlling infection by S. aureus in this model by showing that 
pretreatment of mice with intravitreal injections of the TLR2 ligand Pam3Cys reduced 
bacterial load when compared with mock-injected animals. In summary, the murine model 
of experimental endopthalmitis has proven to be invaluable in analyzing both host and 
bacterial factors that contribute to this disease. The growing number of available genetic 
knockouts in components of the innate and adaptive immune systems and the relative ease 
of use will continue to make the murine model key to understanding the complex interplay 
between host and bacterial factors during the initiation, course, and resolution of 
endophthalmitis.  
6. Conclusions 
Endophthalmitis remains a relatively rare infection, but the potential for vision loss and/or 
blindness is significant. The potential for poor prognosis, which depends on the causative 
organism and the immune status of the patient, remains high despite antibiotic and surgical 
intervention. Research on the contribution of bacterial virulence factors has implicated both 
secreted toxins and proteases, capsules, and the intraocular host response to bacterial cell 
wall components in the pathogenesis of experimental B. cereus, S. aureus, E. faecalis, S. 
pneumoniae, and K. pneumoniae endophthalmitis. Moreover, components of the host 
inflammatory response and mediators of ocular immune privilege have been shown to play 
critical roles in controlling experimental B. cereus and S. aureus endophthalmitis. Virtually 
nothing is known about the contribution of bacterial or host virulence factors to the 
development of EE. The fact that visual prognosis of EE and other types of bacterial 
endophthalmitis caused by pathogenic organisms remains uniformly poor highlights the 
need for continuing research on the interactions between the offending pathogen, the 
internal structures of the eye, underlying disease state and the immune response.  
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